
TYA-018
TYA-018
Catalog No. M36531
TYA-018 is an orally available and selective HDAC6 inhibitor with cardioprotective properties for the study of dilated heart disease and heart failure.TYA-018 prevents sarcomere damage and decreases Nppb expression.
Size | Price / USD | Stock | Quantity |
2MG | 46 | Get Quote |
![]() ![]() |
5MG | 61 | Get Quote |
![]() ![]() |
10MG | 88 | Get Quote |
![]() ![]() |
25MG | 136 | Get Quote |
![]() ![]() |
50MG | 205 | Get Quote |
![]() ![]() |
100MG | 353 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameTYA-018
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. Yang J, et al. Phenotypic screening with deep learning identifies HDAC6 inhibitors as cardioprotective in a BAG3 mouse model of dilated cardiomyopathy. Sci Transl Med. 2022 Jul 6;14(652):eabl5654. ?
molnova catalog



related products
-
Romidepsin
Romidepsin (FK228, depsipeptide) is a potent HDAC1 and HDAC2 inhibitor with IC50 of 36 nM and 47 nM, respectively.
-
LMK-235
A selective HDAC5 and HDAC4 inhibitor with IC50 of 4.22 nM and 11.9 nM respectively.
-
CG347B
CG347B is a selective inhibitor of HDAC6.